FilingReader Intelligence
Pharmaron invests in Ningbo Yongkang equity fund
April 11, 2025 at 05:47 PM UTC•By FilingReader AI
Pharmaron Beijing (SZSE:300759) has confirmed its investment in Ningbo Yongkang Equity Investment Partnership (Limited Partnership). This fund aims to leverage specialized investment expertise to enhance Pharmaron's investment capacity and foster the development of the pharmaceutical industry in Ningbo. The company initially signed the partnership agreement on March 19, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:300759•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Pharmaron Beijing publishes news
Free account required • Unsubscribe anytime